Comparative proteomic profile of the human placenta in normal and fetal growth restriction subjects

Cellular Physiology and Biochemistry

Volumn 34, Issue 5, 2014, Pages 1701-1710

  Miao, Zhijing ^a   Chen, Min ^a   Wu, Hong ^a   Ding, Hongjuan ^a   Shi, Zhonghua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Fetal growth restriction; Oxidative stress; Placenta; TMT

Indexed keywords

PLACENTA PROTEIN; PROTEOME;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FETAL GROWTH RESTRICTION; FETUS GROWTH; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLACENTA; PREGNANCY COMPLICATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; UNINDEXED SEQUENCE; WESTERN BLOTTING; CASE CONTROL STUDY; FETUS DEVELOPMENT; INTRAUTERINE GROWTH RETARDATION; METABOLISM; PHYSIOLOGY; PREGNANCY; PROCEDURES;

ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; HUMANS; PLACENTA; PREGNANCY; PROTEOME; PROTEOMICS;

EID: 84911489498     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366371     Document Type: Article

References (49)

1. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in Preeclampsia. Circ Res 2002;90:1274-1281.
2. Radulescu L, Ferechide D, Popa F: The importance of fetal gender in intrauterine growth restriction. J Med Life 2013;6:38-39.
3. Cox P, Marton T: Pathological assessment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 2009;23:751-764.
4. Spinillo A, Gardella B, Bariselli S, Alfei A, Silini E, Dal Bello B: Placental histopathological correlates of umbilical artery Doppler velocimetry in pregnancies complicated by fetal growth restriction. Prenat Diagn 2012;32:1263-1272.
5. Lyall F, Robson SC, Bulmer JN: Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypentension 2013;62:1046-1054.
6. Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM: Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR. Placenta 2012;33:352-359.
7. Biswas S, Adhikari A, Chattopadhyay JC, Ghosh SK: Histological changes of placentas associated with intrauterine growth restriction of fetuses: a case control study. Nepal Med Coll J 2012;14:18-24.
8. Fowden, AL, Forhead, AJ, Coan, PM. Burton GJ: The Placenta and Intrauterine Programming. J Neuroendocrinol 2008;20:439-450.
9. Mifsud W, Sebire NJ: Placental Pathology in Early-Onset and Late-Onset Fetal Growth Restriction. Fetal Diagn Ther 2014;36:117-128.
10. Todros T, Sciarrone A, Piccoli E, Guiot C, Kaufmann P, Kingdom J: Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction. Obstet Gynecol 1999;93:499-503.
11. Gupta S, Agarwal A, Banerjee J, Alvarez JG: The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review. Obstet Gynecol Surv 2007;62:335-347.
12. Reid MV, Murray KA, Marsh ED, Golden JA, Simmons RA, Grinspan JB: Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4. J Neuropathol Exp Neurol 2012;71:640-653.
13. Al-Gubory KH, Fowler PA, Garrel C: The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010;42:1634-1650.
14. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-166.
15. Crocker IP, Cooper S, Ong SC, Baker PN: Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003;162:637-643.
16. Bevilacqua E, Gomes SZ, Lorenzon AR, Hoshida MS, Amarante-Paffaro AM: NADPH oxidase as an important source of reactive oxygen species at the mouse maternal-fetal interface: putative biological roles. Reprod Biomed Online 2012;25:31-43.
17. Pecks U, Caspers R, Schiessl B, Bauerschlag D, Piroth D, Maass N, Rath W: The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia. Hypertens Pregnancy 2012;31:156-165.
18. Karowicz-Bilinska A, Kedziora-Kornatowska K, Bartosz G: Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic Res 2007;41:870-873.
19. Pecks U, Rath W, Caspers R, Sosnowsky K, Ziems B, Thiesen HJ, Maass N, Huppertz B: Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction. Placenta 2013;34:1142-1149.
20. Randhawa RS: The insulin-like growth factor system and fetal growth restriction. Pediatr Endocrinol Rev 2008;6:235-240.
21. Maulik D, Frances Evans J, Ragolia L: Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol 2006;49:219-227.
22. Huang L, Shen Z, Xu Q, Huang X, Chen Q, Li D: Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction. Placenta 2013;34:624-627.
23. Uhlmann-Schiffler H, Kiermayer S, Stahl H: The DEAD box protein Ddx42p modulates the function of ASPP2, a stimulator of apoptosis. Oncogene 2009;28:2065-2073.
24. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186:158-166.
25. Heazell AE, Sharp AN, Baker PN, Crocker IP: Intra-uterine growth restriction is associated with increased apoptosis and altered expression of proteins in the p53 pathway in villous trophoblast. Apoptosis 2011;16:135-144.
26. Yui J, Garcia-Lloret M, Wegmann TG, Guilber LJ: Cytotoxicity of tumour necrosis factor-alpha and gammainterferon against primary human placental trophoblasts. Placenta 1994;15:819-835.
27. Wadsack C, Tabano S, Maier A, Hiden U, Alvino G, Cozzi V, Hüttinger M, Schneider WJ, Lang U, Cetin I, Desoye G: Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. Am J Physiol Endocrinol Metab 2007;292:E476-484.
28. Merchant SJ, Crocker I P, Baker PN, Tansinda D, Davidge ST, Guilbert LJ: Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Investig 2004;11:97-103.
29. Nuzhat Ahmed, Gillian Barker, Karen Oliva, David Garfin, Kenneth Talmadge, Harry Georgiou, Michael Quinn, Greg Rice: An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics 2003;3:1980-1987.
30. Xu B, Hua J, Zhang Y, Jiang X, Zhang H, Ma T, Zheng W, Sun R, Shen W, Sha J, Cooke HJ, Shi Q: Proliferating cell nuclear antigen (PCNA) regulates primordial follicle assembly by promoting apoptosis of oocytes in fetal and neonatal mouse ovaries. PloS one 2011;6:e16046.
31. Ushio-Fukai M: Localizing NADPH oxidase-derived ROS. Sci STKE 2006;2006:re8.
32. Agarwal A, Gupta S, Sekhon L, Shah R: Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10:1375-1403.
33. Luo Z C, Fraser W D, Julien P, Deal CL, Audibert F, Smith GN, Xiong X, Walker M: Tracing the origins of "fetal origins" of adult diseases: programming by oxidative stress. Med Hypotheses 2006;66:38-44.
34. Chavatte-Palmer P, Al Gubory K, Picone O, Heyman Y: Maternal nutrition: effects on offspring fertility and importance of the periconceptional period on long-term development. Gynecol Obstet Fertil 2008;36:920-929.
35. Mert I, Oruc AS, Yuksel S, Cakar ES, Buyukkagnici U, Karaer A, Danisman N: Role of oxidative stress in preeclampsia and intrauterine growth restriction. J Obstet Gynaecol Res 2012;38:658-664.
36. Stanley J L, Andersson I J, Hirt C J, Moore L, Dilworth MR, Chade AR, Sibley C P, Davidge ST, Baker PN: Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction. Biol Reprod 2012;87:251-258.
37. Biri A, Bozkurt N, Turp A, Kavutcu M, Himmetoglu O, Durak I: Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest 2007;64:187-192.
38. Serres F, Blanco I: Role of alpha-1 antitrypsin in human health and disease. J Intern Med 2014. doi: 10.1111/joim.12239.
39. Janciauskiene S, Lindgren S: Human monocyte activation by cleaved form of alpha-1-antitrypsin. Eur J Biochem 1999;265:875-882.
40. Ueda M, Mashiba S, Uchida K: Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative a1-AT monoclonal antibody. Clin Chim Acta 2002;317:125-131.
41. Mohsenin V, Gee JL: Oxidation of a1-proteinase inhibitor: role of lipid peroxidation products. J Appl Physiol 1989;66:2211-2215.
42. Moraga F, Janciauskiene S: Activation of primary human monocytes by the oxidized form of a1-antitrypsin. J Biol Chem 2000;275:7693-7700.
43. Karowicz-Bilinska A, Suzin J, Sieroszewski P: Evaluation of oxidative stress indices during treatment in pregnant women with intrauterine growth retardation. Med Sci Monit 2002;8:CR211-216.
44. Spong C Y, Abebe D T, Gozes I, Brenneman DE, Hill JM: Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. J Pharmacol Exp Ther 2001;297:774-779.
45. Miller SL, Yawno T, Alers NO, Castillo-Melendez M, Supramaniam VG, Van Zyl N, Sabaretnam T, Loose JM, Drummond GR, Walker DW, Jenkin G, Wallace EM: Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. J Pineal Res 2014;56:283-294.
46. Weiner CP, Williamson RA: Evaluation of severe growth retardation using cordocentesis-hematologic and metabolic alterations by etiology. Obstet Gynecol 1989;73:225-229.
47. Steer PJ: Maternal hemoglobin concentration and birth weight. Am J Clin Nutr 2000;71:1285s-1287s.
48. Salas SP, Marshall G, Gutiérrez BL, Rosso P: Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 2006;47:203-208.
49. Sharp AN, Heazell AE, Crocker IP, Mor G: Placental apoptosis in health and disease. Am J Reprod Immunol 2010;64:159-169.